International Journal of STD & AIDS > Volume 7, Supplement 1 > Pp. 13-14

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mashkilleyson, A L Articles by Kutin, S A Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Treatment of syphilis with azithromycin

A L Mashkilleyson, M A Gomberg, N Mashkilleyson and S A Kutin

The efficacy of oral azithromycin (500 mg daily for 10 days or 500 mg on alternate days for 11 days) in 100 patients with seropositive syphilis was studied. Clinical manifestations regressed more rapidly in azithromycin-treated patients compared with patients who received erythromycin or penicillin, and there was also a more rapid reduction in serum antibody levels. In 90.3% of patients, the complete resolution of classic serological tests was observed within 4 months of completion of the azithromycin treatment. The immobilization (TPI) test and absorbed fluorescent treponema antibody tests became negative 12 months after treatment in 40% of patients. After 4 years of follow-up, no symptoms of neurosyphilis or syphilitic changes of visceral organs were observed.

Key Words: AZITHROMYCIN • SYPHILIS • PENICILLIN • ERYTHROMYCIN • CHANCRE

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P French, M Gomberg, M Janier, B Schmidt, P van Voorst Vader, and H Young IUSTI: 2008 European Guidelines on the Management of Syphilis Int J STD AIDS, May 1, 2009; 20(5): 300 - 309. [Full Text] [PDF]

				M. W. Pandori, C. Gordones, L. Castro, J. Engelman, M. Siedner, S. Lukehart, and J. Klausner Detection of Azithromycin Resistance in Treponema pallidum by Real-Time PCR Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3425 - 3430. [Abstract] [Full Text] [PDF]

				S. A. Lukehart, C. Godornes, B. J. Molini, P. Sonnett, S. Hopkins, F. Mulcahy, J. Engelman, S. J. Mitchell, A. M. Rompalo, C. M. Marra, et al. Macrolide Resistance in Treponema pallidum in the United States and Ireland N. Engl. J. Med., July 8, 2004; 351(2): 154 - 158. [Full Text] [PDF]

				U.S. Preventive Services Task Force Screening for Syphilis Infection: Recommendation Statement Ann. Fam. Med, July 1, 2004; 2(4): 362 - 365. [Full Text] [PDF]

				E. Martin The importance of assessing and treating sexual dysfunction in the cardiac patient The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 324 - 326. [Abstract] [PDF]